Pricing

Asklepios BioPharmaceutical

1 follower

‌

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Industries

Biotechnology, Health Care

Headquarters

Chapel Hill, United States

Employees

51-200

Links

Org chart

Gustavo Pesquin

CEO

Gustavo Pesquin

Collapse

R. Jude Samulski

President, Chief Scientific Officer & Co-Founder

Canwen Jiang

Chief Development Officer & CMO

Josh Grieger

CTO

Candace Summerford

Chief Patent Officer

Tracy Dowling

General Counsel & Head of Business Development

Mansuo L Shannon

Board Member

Melissa Murrell

Chief People Officer

Teams

Leadership Team

4 members

Business Development and Strategy

5 members

Clinical Operations

3 members

Regulatory and Quality Assurance

3 members

Similar companies

Merck

210 followers

Invivyd

1 follower

Abeona Therapeutics

1 follower

Annexon Biosciences

2 followers

Immunai

2 followers

Abridge

3 followers

Fabric

3 followers

Liquid I.V.

2 followers

Thermo Fisher Scientific

155 followers

Agilent Technologies

63 followers

Myriad Genetics

35 followers

Explore companies